Pain management is a branch of medical science that reduces the pain of patients with chronic pain. Acute pain is the onset of (short-lived) sudden action, whereas chronic pain persists for a long time, due to which pain management is needed. Pain management devices are often used for pain relief. They are used to manage different types of pain such as musculoskeletal pain, nociceptive pain, cancer pain, neuropathic pain, and others. These devices can be used to both manage and reduce pain in many areas of the body, and thus, there is an increasing demand for pain management devices worldwide.
Market Dynamics:
Increasing demand for chronic pain management, High prevalence of neurological disorders, growing geriatric population, growing number of surgical procedures performed, and increase in research and development activities are some major factors expected to boost the growth of the pain management devices market during the forecast period. Chronic pain is a massive and growing issue in the United States. Over 110 million Americans experience chronic pain, more than diabetes, heart disease, and cancer combined. Therefore, in June 2022, Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, and Capitol Pain Institute, an interventional pain management provider, teamed up to create physician-led consolidation platform focused on delivering the highest quality care for patients with chronic pain.
Key features of the study:
- This report provides in-depth analysis of the global pain management devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pain management devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Stryker Corporation, Pfizer Inc. (Hospira Inc.), Medtronic Plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Abbott Laboratories, Colfax Corporation (Djo Global LLC), Kimberly-Clark Corporation (Baylis Medical), and Johnson & Johnson (Codman and Shurtleff, Inc.), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global pain management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pain management devices market.
Detailed Segmentation:
- Global Pain Management Devices Market, By Type:
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps
- Ablation Devices
- Global Pain Management Devices Market, By Application:
- Neuropathic Pain
- Cancer Pain
- Facial & Migraine Pain
- Musculoskeletal Pain
- Others
- Global Pain Management Devices Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America